Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD47 (clone C5L/D5L). We employs the pUC (SV40-RFP-IL-4-HindIII) vector components and the SynExpress system of the Introns Substitution/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD47
Clone
C5L/D5L
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
SV40
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
pUC
Transformation Accuracy
0.95
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.